Ranal Gurbanov | Cancer Research | Best Researcher Award

Mr. Ranal Gurbanov | Cancer Research | Best Researcher Award

Medical Student at Gazi University School of Medicine, Turkey.

Ranal Gurbanov, an Azerbaijani national born on May 2, 2004, is a promising young individual with a strong academic and humanitarian profile. He earned a bronze medal in the 2019 National Biology Olympiad and participated in the Future Leaders Exchange Program (FLEX) in the U.S., gaining valuable cultural and leadership experiences. Ranal has been recognized for academic excellence by the Baku Department of Education and is actively involved in community service through the “Social and Active Doctors Community (GÜTSAH)” and “KANOPE Blood and Organ Donation Community.” These roles demonstrate his commitment to supporting children with chronic diseases and raising awareness about blood and organ donation. Additionally, Ranal has pursued specialized medical training from prestigious institutions such as the University of Pennsylvania and Acıbadem University. His profile reflects a blend of academic achievement, leadership, and dedication to public health, though he would benefit from further research contributions to strengthen his candidacy for awards.

Profile:

Education

Ranal Gurbanov’s education reflects a strong commitment to academic excellence and personal growth. He began his educational journey with notable achievements at Baku High School No:102, where his exceptional talents earned him an Academic Excellence Award from the Baku Department of Education in 2021. Following this, Ranal participated in the Future Leaders Exchange Program (FLEX), which provided him with an opportunity to study at an American high school and experience a different educational and cultural environment. His commitment to furthering his knowledge is evident in his enrollment in various specialized medical training programs. These include “Vital Signs: Understanding What the Body Is Telling Us” by the University of Pennsylvania, “Clinical Terminology for International and U.S. Students” by the University of Pittsburgh, and several clinical risk management and forensic medicine courses offered by Acıbadem University. This diverse educational background highlights his dedication to both academic and practical learning.

Professional Experience

Ranal Gurbanov has actively engaged in various professional and extracurricular roles that reflect his commitment to both academic excellence and community service. He earned a bronze medal in the 2019 National Biology Olympiad, demonstrating his strong foundational knowledge in biology. His participation in the Future Leaders Exchange Program (FLEX) allowed him to study in the U.S., gaining invaluable cultural and leadership experience. In his volunteer work, Ranal has contributed to the “Social and Active Doctors Community (GÜTSAH),” where he helps improve the lives of children with chronic diseases through moral support and gifts. Additionally, his role in the “KANOPE” Blood and Organ Donation Community showcases his efforts to raise awareness about organ and blood donation, addressing critical healthcare issues in Turkey. His involvement in various medical training programs further highlights his dedication to understanding and improving clinical practices.

Research Interest

Ranal Gurbanov’s research interests are rooted in the intersection of biology, medical ethics, and community health. His early achievements in the National Biology Olympiad reflect a strong foundation in biological sciences, while his academic journey has been enriched by global experiences through the FLEX program, which broadened his understanding of diverse health systems. Ranal’s current focus includes exploring the ethical dimensions of organ donation and transplantation, a field he actively engages in through his role in the “KANOPE Blood and Organ Donation Community.” His interest also extends to clinical risk management and forensic medicine, evidenced by his participation in specialized training programs. Ranal is particularly motivated by addressing public health challenges and improving patient care through innovative approaches. His commitment to community service, coupled with his academic pursuits, underscores a desire to integrate scientific research with practical applications in healthcare.

Research Skills

Ranal Gurbanov has demonstrated a strong foundation in research through his participation in diverse educational and community activities. His involvement in the National Biology Olympiad and subsequent achievements highlight his solid grasp of biological sciences and scientific inquiry. Ranal’s engagement in specialized medical training programs, such as “Vital Signs” and “Clinical Risk Management,” reveals his commitment to understanding complex clinical concepts and research methodologies. Additionally, his role in organizing blood and organ donation awareness campaigns reflects his ability to translate scientific knowledge into public health initiatives. Although his profile is more focused on community service and humanitarian work, these experiences have honed his skills in communication, project management, and ethical considerations in healthcare. To further enhance his research skills, Ranal could benefit from direct involvement in scientific research projects and publications, which would solidify his expertise and contribute to his development as a researcher.

Award and Recognition

Ranal Gurbanov has received notable awards and recognition for his exceptional achievements and contributions. In 2019, he earned a bronze medal at the National Biology Olympiad organized by the Azerbaijan Ministry of Education, highlighting his early excellence in biological sciences. His leadership and adaptability were further recognized when he won the Future Leaders Exchange Program (FLEX) scholarship, allowing him to study in the U.S. and experience diverse cultural values. Additionally, he was honored with the Academic Excellence Award by the Baku Department of Education in 2021 for his outstanding academic performance at Baku High School No:102. Ranal’s commitment to social causes is evident through his active roles in the “Social and Active Doctors Community (GÜTSAH)” and the “KANOPE Blood and Organ Donation Community,” where he has contributed significantly to public health awareness and support for patients with chronic conditions.

Conclusion

Ranal Gurbanov shows tremendous potential and passion, especially in humanitarian and community-driven projects. However, to be a strong candidate for the Best Researcher Award, he needs to enhance his research output and demonstrate more direct contributions to the scientific field through publications or significant research findings. His commitment to learning and social impact is commendable, and with further academic and research development, he could emerge as a future contender.

Publication Top Notes

Ovatodiolide Inhibits Endometrial Cancer Stemness via Reactive Oxygen Species-Mediated DNA Damage and Cell Cycle Arrest

  • Journal: Chemico-Biological Interactions
  • Year: 2024
  • DOI: 10.1016/j.cbi.2024.111244
  • Authors: Chun-Yu Chen, Yu-Zhen Ye, Yu-Hao Huang, Yew-Min Tzeng, Ranal Gurbanov, Wen-Ling Wang, Wen-Wei Chang

 

Mrinal Ghosh | Cancer Biology | Best Researcher Award

Prof. Mrinal Ghosh | Cancer Biology | Best Researcher Award

Chief Scientist at CSIR-Indian Institute of Chemical Biology, India

Dr. Mrinal K. Ghosh is a distinguished Chief Scientist at the CSIR-Indian Institute of Chemical Biology and a Professor at AcSIR, New Delhi. With a Ph.D. in Biochemistry from the University of Calcutta, Dr. Ghosh specializes in cancer biology and inflammatory disorders. His extensive career includes leadership roles at CSIR-IICB and significant contributions to cancer research, particularly in glioma and breast cancer therapies. He has secured substantial funding for projects focusing on novel nanotechnology-based treatments and peptide therapeutics. Dr. Ghosh’s work has earned him prestigious awards such as the Bharat Vikash Award and recognition as a Fellow of the National Academy of Science & Technology. He is an active member of various scientific societies and has a robust publication record in high-impact journals. His research integrates advanced molecular biology techniques and translational medicine to address critical challenges in oncology.

Profile

Education

Dr. Mrinal K. Ghosh completed his education with a strong foundation in biochemistry and molecular biology. He earned his Ph.D. in Biochemistry from the University of Calcutta, India, where he conducted extensive research in the field from 1991 to 1997. Prior to his doctoral studies, Dr. Ghosh obtained his Master of Science degree in Biochemistry, with a focus on Molecular Biology, from the same institution in 1990. His undergraduate studies were in Chemistry, with honors, complemented by Physics and Mathematics, also at the University of Calcutta, culminating in his Bachelor of Science degree in 1988. Dr. Ghosh’s academic journey laid a solid groundwork for his subsequent research and leadership roles in cancer biology and inflammatory disorders, significantly contributing to his reputation as a leading scientist in his field.

Professional Experience

Dr. Mrinal K. Ghosh is a distinguished scientist with a remarkable career in cancer biology and inflammatory disorders. Currently serving as the Chief Scientist and Head of the Cancer Biology & Inflammatory Disorder Division at CSIR-Indian Institute of Chemical Biology (CSIR-IICB), he has been instrumental in advancing research in these fields. Prior to this role, he held positions as Senior Principal Scientist and Principal Scientist at CSIR-IICB, showcasing a trajectory of increasing responsibility. His earlier career included roles as Senior Lecturer at the Department of Biotechnology, HIT, Kolkata, and research positions at the Cleveland Clinic Foundation in the USA. Dr. Ghosh’s extensive experience includes leading significant research projects, managing research teams, and contributing to scientific advancements through his various roles and memberships in professional societies. His career is marked by his dedication to translating scientific discoveries into therapeutic innovations.

Research Interest

Dr. Mrinal K. Ghosh’s research interests focus on advancing cancer biology and inflammatory disorders through innovative biochemical and molecular approaches. His work emphasizes understanding the molecular mechanisms underlying cancer progression, particularly in glioma and breast cancer. Dr. Ghosh investigates the roles of key proteins and signaling pathways, including the p53 and Rb tumor suppressor proteins, and the ubiquitin-proteasome system in regulating cancer cell behavior. His research integrates nanotechnology and peptide therapeutics to develop novel treatment strategies, aiming to enhance the effectiveness of current therapies and overcome resistance. Additionally, Dr. Ghosh explores the implications of cancer biology in the context of stem cell research and neurodegenerative diseases. His comprehensive approach combines preclinical validation, clinical insights, and cutting-edge technology to address critical challenges in cancer treatment and provide new avenues for therapeutic interventions.

Research Skills

Dr. Mrinal K. Ghosh demonstrates exceptional research skills in the field of cancer biology and inflammatory disorders. His expertise spans molecular and cellular mechanisms, particularly in signal transduction related to cancer and stem cells. Dr. Ghosh is proficient in advanced techniques such as nanotechnology-based therapeutic systems, biomolecular target identification, and peptide therapeutic design. His research includes pre-clinical validation of therapies, focusing on glioma and breast cancer, utilizing sophisticated methods like protein modification and nanoparticle-based delivery systems. Dr. Ghosh’s ability to lead large-scale, multi-disciplinary projects is evident from his successful management of significant research grants and collaborations. His extensive publication record in high-impact journals and his role as a reviewer for leading scientific journals highlight his critical analytical skills and contribution to the scientific community. His innovative approach and comprehensive understanding of cancer biology underscore his research prowess.

Award and Recognition

Dr. Mrinal K. Ghosh has garnered significant recognition for his pioneering research in cancer biology and inflammatory disorders. His contributions have been acknowledged through numerous prestigious awards, including the Bharat Vikash Award in 2019, which honors outstanding achievements in scientific research. Dr. Ghosh is also a Fellow of the National Academy of Science & Technology (FNASc) and the Academy of Science & Technology (FAScT), reflecting his esteemed status within the scientific community. His research excellence is further underscored by his role as the Principal Investigator in several high-impact projects, such as the PAN-CSIR Cancer Research initiative and various DST-Nano Mission projects. Additionally, Dr. Ghosh has been honored with the Outstanding Scientist Award on Strategic Management and Business Strategy in 2023. These accolades, coupled with his extensive contributions to scientific literature and research, solidify his standing as a leading figure in his field.

Conclusion

Dr. Mrinal K. Ghosh is highly deserving of the Best Researcher Award due to his outstanding contributions to cancer biology and inflammatory disorders, as evidenced by his awards, extensive research funding, and high-impact publications. His leadership roles and recognition in the scientific community further underscore his excellence. Addressing areas such as enhancing international collaborations and increasing public engagement could further amplify his impact and align with broader scientific and societal goals.

Publications Top Notes

  1. MGMT in TMZ-based Glioma therapy: Multifaceted Insights and Clinical Trial Perspectives
    • Authors: Shaw R, Basu M, Karmakar S, Ghosh MK*
    • Journal: BBA – Molecular Cell Research
    • Year: 2024
    • Volume and Issue: 1871, 119673
    • Impact Factor: 5.1
    • Citations: 0
  2. Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling
    • Authors: Ghosh MK*, Roy S
    • Journal: Molecular Biomedicine
    • Year: 2024
    • Volume and Issue: 5(4)
    • Impact Factor: 6.0
    • Citations: 0
  3. E3 Ubiquitin Ligases in Lung Cancer: Emerging Insights and Therapeutic Opportunities
    • Authors: Basu B, Kal S, Karmakar S, Basu M, Ghosh MK*
    • Journal: Life Sciences
    • Year: 2024
    • Volume and Issue: 336, 122333
    • Impact Factor: 6.1
    • Citations: 0
  4. Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives
    • Authors: Kumar S#, Ansari A#, Basu M#, Ghosh S#, Begam S#, Ghosh MK#*
    • Journal: Advanced Therapeutics
    • Year: 2024
    • Impact Factor: 4.6
    • Citations: 0
    • Status: In press
  5. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
    • Authors: Kumar S, Basu M, Ghosh MK*
    • Journal: BBA – Molecular Cell Research
    • Year: 2024
    • Volume and Issue: 1871, 119673
    • Impact Factor: 5.1
    • Citations: 0
    • Status: In press
  6. Glioma Immunotherapy: Exploring Molecular and Clinical Frontiers
    • Authors: Ghosh MK*, Kumar S, Begam S, Ghosh S, Basu M
    • Journal: Life Sciences
    • Year: 2024
    • Impact Factor: 5.2
    • Citations: 0
    • Status: In press
  7. Glioma nanotherapy: Unleashing the synergy of dual-loaded DIM and TMZ
    • Authors: Sarkar S#, Kumar S#, Saha G, Basu M, Ghosh MK*
    • Journal: International Journal of Pharmaceutics
    • Year: 2024
    • Impact Factor: 5.3
    • Citations: 0
    • Status: Under Review (R1)
  8. Unraveling COVID-19 diagnostics: A roadmap for future pandemic
    • Authors: Kumar S, Basu M*, Chakraborty D, Ghosh P, Bajoria S, Ghosh MK*
    • Journal: Nature Cell & Sciences
    • Year: 2024
    • Status: Under Review

2023 Publications:

  1. USP7 – A crucial regulator of Cancer Hallmarks
    • Authors: Saha G, Roy S, Basu M, Ghosh MK*
    • Journal: BBA – Reviews on Cancer
    • Year: 2023
    • Volume and Issue: 1878, 188903
    • Impact Factor: 11.2
    • Citations: 10
  2. Neurological damages in COVID-19 patients: mechanisms and preventive interventions
    • Authors: Sarkar S#, Karmakar S#, Basu M, Ghosh P, Ghosh MK*
    • Journal: MedComm
    • Year: 2023
    • Volume and Issue: 4, e247,1-25
    • Impact Factor: 10.7
    • Citations: 10

 

Mohammed Kashani-Sabet | Oncology | Best Researcher Award

Dr. Mohammed Kashani-Sabet | Oncology | Best Researcher Award

Medical Director, Oncology Service Line, Sutter Health at California Pacific Medical Center Research Institute, United States.

Dr. Mohammed Kashani-Sabet is a distinguished medical professional with extensive expertise in dermatology and oncology. Holding multiple leadership positions, including Medical Director of the Oncology Service Line at Sutter Health and the Cancer Center at California Pacific Medical Center, he has made significant contributions to cancer research and treatment. Dr. Kashani-Sabet received his medical education from renowned institutions such as Harvard University and the State University of New York at Stony Brook. Throughout his career, he has been involved in groundbreaking research focused on melanoma, cutaneous T-cell lymphoma, targeted therapy, and tumor biomarkers. He has received numerous honors and awards for his contributions to the field, including the Clinical Career Development Award from the Dermatology Foundation and the Patients’ Choice Award by Sutter Medical Network. Dr. Kashani-Sabet’s dedication to improving patient care and advancing cancer treatment has earned him widespread recognition and respect in the medical community.

Professional Profiles:

Education:

Dr. Mohammed Kashani-Sabet embarked on his academic journey with a Bachelor’s degree in Biochemical Sciences from Harvard University, followed by a Doctorate in Medicine from the State University of New York at Stony Brook. After completing his medical education, he undertook an internship in Internal Medicine and residency in Dermatology at the State University of New York at Stony Brook and the University of California, San Francisco (UCSF) respectively. Dr. Kashani-Sabet further honed his expertise through a post-doctoral fellowship in Cutaneous Oncology at UCSF’s Department of Dermatology and Division of Hematology/Oncology. This comprehensive educational background laid a robust foundation for his subsequent career as a renowned physician and researcher in the field of dermatology and oncology.

Professional Experience:

Dr. Mohammed Kashani-Sabet has held several prestigious positions throughout his career, demonstrating his leadership and expertise in the field of dermatology and oncology. Currently, he serves as the Medical Director of the Oncology Service Line at Sutter Health and as the Medical Director of the Cancer Center at California Pacific Medical Center. Additionally, he holds the position of Medical Director of the Center for Melanoma Research and Treatment at Sutter West Bay Medical Group, Sutter Pacific Medical Foundation, and California Pacific Medical Center. Dr. Kashani-Sabet also contributes significantly to research as a Senior Scientist at the California Pacific Medical Center Research Institute. His extensive professional experience spans over two decades and encompasses various roles in academia, clinical practice, and administrative leadership within prestigious institutions such as the University of California, San Francisco (UCSF) and the California Pacific Medical Center.

Research Focus:

Dr. Mohammed Kashani-Sabet’s research focus encompasses a broad spectrum of topics within dermatology and oncology, with a particular emphasis on melanoma and cutaneous T-cell lymphoma. His work includes investigating novel targeted therapies, such as ribozymes and siRNAs, for these malignancies. Additionally, he explores tumor metastasis, prognostic modeling, and tumor biomarkers to advance our understanding of these diseases and improve patient outcomes. Dr. Kashani-Sabet’s research efforts aim to translate scientific discoveries into clinical applications, with the ultimate goal of developing more effective treatments and interventions for patients with melanoma and cutaneous T-cell lymphoma.

Research Interest:

Dr. Mohammed Kashani-Sabet possesses a diverse set of research skills honed over years of experience in dermatology and oncology. His expertise includes clinical research, where he designs and conducts studies to evaluate novel therapies for melanoma and cutaneous T-cell lymphoma. In the laboratory, he is skilled in various techniques such as PCR, DNA sequencing, and gene expression analysis, essential for basic and translational research. Dr. Kashani-Sabet also excels in data analysis, utilizing statistical methods and software to interpret clinical and experimental data effectively. With a track record of publishing research findings in peer-reviewed journals, he demonstrates proficiency in scientific writing and manuscript preparation. Additionally, his ability to write grant proposals and collaborate with interdisciplinary teams underscores his commitment to advancing dermatologic oncology research and improving patient care.

Award and Honors:

Dr. Mohammed Kashani-Sabet has been recognized with numerous awards and honors throughout his career, reflecting his exceptional contributions to dermatologic oncology research and patient care. Among these accolades are the Clinical Career Development Award from the Dermatology Foundation in 1997 and the Herschel and Diana Zackheim Endowed Chair in Cutaneous Oncology in the same year. His dedication to teaching and mentorship was acknowledged with the Teacher of the Year Award in 2004, bestowed upon him by the Dermatology Residents at UCSF. Notably, Dr. Kashani-Sabet received the Patients’ Choice Award in 2013 from the Sutter Medical Network for achieving high patient satisfaction scores. His humanitarian efforts were recognized with the Humanitarian Award by the Melanoma Research Foundation in 2014. Moreover, he holds the Chair in Melanoma Research and Treatment at California Pacific Medical Center since 2015, a testament to his leadership and contributions to the field.

Publications:

  1. Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures
    • Authors: Chang, S.H., Ice, R.J., Chen, M., … Soroceanu, L., McAllister, S.D.
    • Citations: 0
    • Year: 2023
  2. Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing
    • Authors: Kashani-Sabet, M., Leachman, S.A., Stein, J.A., … Venna, S., Kirkwood, J.M.
    • Citations: 6
    • Year: 2023
  3. Improving Selection for Sentinel Lymph Node Biopsy among Patients with Melanoma
    • Authors: Miller, J.R., Lo, S.N., Nosrati, M., … Scolyer, R.A., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2023
  4. Erratum: Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
    • Authors: Dar, A.A., Bezrookove, V., Nosrati, M., … McAllister, S., Kashani-Sabet, M.
    • Citations: 0
    • Year: 2023
  5. Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
    • Authors: Sidorov, M., Dighe, P., Woo, R.W.L., … McAllister, S.D., Soroceanu, L.
    • Citations: 7
    • Year: 2023
  6. Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas
    • Authors: Minor, D.R., Kim, K.B., Karuturi, R.K.M., Kashani-Sabet, M.
    • Citations: 0
    • Year: 2023
  7. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients
    • Authors: Balkin, D.M., Tranah, G.J., Wang, F., … Zager, J.S., Leong, S.P.
    • Citations: 0
    • Year: 2023
  8. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
    • Authors: Bezrookove, V., Khan, I.A., Nosrati, M., … Dar, A.A., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2022
  9. Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
    • Authors: Chen, M., Jian, D., Sidorov, M., … McAllister, S.D., Desprez, P.-Y.
    • Citations: 2
    • Year: 2022
  10. Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
    • Authors: Dar, A.A., Bezrookove, V., Nosrati, M., … McAllister, S., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2022